Target intelligence / Profile preview

Homeobox protein MSX-1 (MSX1)

Target
MSX1
Molecular classification
Transcription factor, Homeobox gene family
01

Overview

Homeobox protein MSX-1 is a transcription factor encoded by the MSX1 gene, belonging to the muscle segment homeobox (MSX) family. Highly conserved across species, MSX1 plays a pivotal role in the regulation of gene expression during embryonic development, particularly in craniofacial patterning, tooth development (odontogenesis), limb formation, and tumor growth inhibition. The protein contains a homeodomain enabling DNA binding and protein-protein interactions, allowing it to repress or activate transcription depending on its binding partners, and is critical for normal development of teeth, mouth, nails, and other tissues. Mutations or deletions in MSX1 can cause a variety of syndromes and isolated defects (such as cleft lip/palate, tooth agenesis, and nail disorders) and impair normal embryogenesis and tumor suppression. There are currently no approved drugs directly targeting MSX1, but its methylation status can serve as a biomarker for tumor progression, particularly in breast cancer.

Other names
Msh homeobox 1Homeobox protein MSX-1HOX7HYD1OFC5Homeobox protein Hox-7ECTD3STHAG1Homeobox 7Msh homeobox homolog 1
02

Mechanism of action

Not applicable for existing drugs; MSX1 modulates transcriptional activity via: - Sequence-specific binding to DNA at MSX1 motif - Protein-protein interactions with other transcription factors (Sp1, Sp3, Dlx3, Dlx5, PAX3, PAX9, BARX1, PIAS1)

03

Biological functions

Embryonic pattern formationTranscriptional repression during embryogenesisCraniofacial development (palatogenesis, odontogenesis)Limb-pattern formationCell proliferationCell cycle regulationApoptosisTumor growth inhibition
04

Disease associations

Tooth agenesis (selective, nonsyndromic, or part of syndromes)Cleft lip and/or palate (especially nonsyndromic)Witkop syndromeWolf–Hirschhorn syndromeTumor suppression (breast cancer, others)Nail disorders (as part of syndromic presentation)
05

Safety considerations

Developmental defects (teeth, craniofacial structure, nails)Tumor suppressor loss (potential cancer risk if inactivated)
06

Biomarkers

MSX1 gene/protein methylation status (particularly in breast cancer, potential biomarker of tumor suppression)Mutation analysis for selection or diagnosis in tooth agenesis, cleft lip/palate, and related syndromes

Beyond the preview

Go deeper on Homeobox protein MSX-1 (MSX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeobox protein MSX-1 (MSX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call